Epizyme Inc. (EPZM) Return on Investment ROI from the second quarter of 2022 to second quarter of 2021 and for the year 2022, average high and low, overall ranking from Jun 30 2022 to Jun 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Epizyme Inc.  (NASDAQ: EPZM)


Epizyme's ROI from its second quarter of 2022 to the second quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Epizyme's ROI in the second quarter of 2022?
Epizyme Inc. recorded a cumulative net loss of $-208 million during 12 months ending in the second quarter of 2022, resulting in a negative return on investment (ROI) of -80.38%.

Within the Healthcare sector 857 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2022 from 0 to 4884.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Investment Change TTM -29.02 % -27.59 % -24.25 % -10.35 % -3.93 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 229 273 244 288 312
Return On Investment (TTM) -80.38 % -84.7 % -82.97 % -76.36 % -70.56 %
EPZM's Overall Ranking # 4884 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -7.39 % -7.8 % -13.34 % -4.08 % -5.52 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -208 -236 -251 -267 -257

EPZM Company Profile >> Back to EPZM Roi Comparisons >> See Annual EPZM Return On Investment



Return On Investment EPZM's Ranking
Within: No.
Industry # 395
Sector # 858
Overall # 4884

Return On Investment Statistics
High Average Low
-36.97 %
-55.47 %
-77.86 %
(Sep 30 2016)   (Mar 31 2022)







Financial Statements
Epizyme's II. Quarter Investments $ 229 Millions EPZM's Balance sheet
Epizyme's II. Quarter Income $ -36 Millions Quarterly EPZM's Income Statement
EPZM's Income by Division See EPZM's Income by Division


EPZM Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 244 430 390 234 265
Y / Y Investment Growth -43.32 % 10.24 % 66.85 % -11.65 % 14.68 %
Net Income in Millions -251 -232 -170 -124 -134
Y / Y Net Income Growth - - - - -
Annual Return On Investment -103 % -53.86 % -43.64 % -52.86 % -50.74 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EPZM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EPZM's Competitors
Subscribers only: Roi for Epizyme's Suppliers
Subscribers only: Return On Investment for EPZM's Customers

Other Ratios
EPZM's Roa EPZM's Inventory Turnover Ratio EPZM's Growth Rates EPZM's Dividend Statistics
EPZM's Profitability Ratios EPZM's Asset Turnover Ratio EPZM's Dividend Growth
EPZM's Roe EPZM's Valuation Ratios EPZM's Financial Strength Ratios EPZM's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2022, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.